TickerStat.com

Odyssey Therapeutics, Inc. (ODTX)

Price—Loading quote

Financial charts

Revenue

Net income

Free cash flow

No reported data

Total cash / debt

CashTotal debt

Financial statements

2 annual periodsNewest to oldest
20252024
Revenue$1,986$382
Research & development$61,894$75,669
Net income$31$2,025
Diluted EPSper diluted share$31.00$2,025.00
Review source filings at SEC.gov ↗

Insider buys & sells

Jul 1, 2024–Jun 30, 2026
Buys9$75.32M disclosed value
Sells (SEC code S)3$32.0K disclosed value
12 recent transactions
TransactionInsiderTypeSharesPriceValueOwned after
May 11, 2026Form 4COULTER JAMES G +2OtherBuyCommon Stock · indirect1.39M$18.00$25.00M3.69M
May 11, 2026Form 4George Simeon +1TenPercentOwnerBuyCommon Stock · indirect200.0K$18.00$3.60M1.01M
May 11, 2026Form 4George Simeon +1TenPercentOwnerSellCommon Stock · indirect438$18.00$7.9K814.9K
May 11, 2026Form 4George Simeon +1TenPercentOwnerBuyCommon Stock · indirect133.3K$18.00$2.40M574.3K
May 11, 2026Form 4George Simeon +1TenPercentOwnerSellCommon Stock · indirect277$18.00$5.0K441.0K
Review ownership filings at SEC.gov ↗